Catalyst Wire Dossier Catalyst Wire Dossier

Nefopam 30 mg tablets

nefopam
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nefopam 30 mg tablets, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology [Phase 4]

See pricing